Used primarily in pharmaceutical research as a potent serotonin receptor antagonist. It exhibits strong affinity for 5-HT2A and 5-HT2C receptors, making it valuable in the study of central nervous system disorders such as depression, anxiety, and schizophrenia. Its structure supports high blood-brain barrier penetration, enhancing its utility in neuropharmacological studies. Also investigated for potential antipsychotic and anxiolytic drug development due to its selective receptor binding and metabolic stability. Commonly employed as a reference compound in receptor binding assays and in the optimization of novel psychoactive therapeutics.